Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.00
Ask: 18.50
Change: 4.00 (29.09%)
Spread: 1.50 (8.824%)
Open: 16.25
High: 18.25
Low: 15.25
Prev. Close: 13.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale

Thu, 29th Oct 2020 14:46

(Alliance News) - The following is a round-up of earnings reports by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Gfinity PLC - London-headquartered e-sports firm - Revenue down 43% in financial year ended June 30 to GBP4.5 million from GBP7.9 million. Pretax loss narrows to GBP8.2 million from GBP12.1 million. Says it is looking towards exploiting the "explosive" growth it has seen through making acquisitions, forming partnerships, separating activities of the group, or a potential sale of the company. Says this strategic growth review, first announced earlier in October, is being overseen by investment bank FinnCap Group PLC and is "progressing as planned".

----------

Aberdeen Standard Asia Focus PLC - investment trust that aims to identify market leading businesses in Asia - Posts net asset value per share at July 31 of 1,106.45 pence, down 15% from 1,300.56 pence a year prior. NAV total return was negative 14% versus the MSCI AC Asia Pacific ex Japan Index total return benchmark of positive 1.9%. Declares final dividend of 4.5 pence per share, down from 5.0p a year before. Says investments look "undimmed" in the long-run despite the pandemic.

----------

Sealand Capital Galaxy Ltd - Cayman Islands-based investment company - Revenue more than doubles in the half year ended June 30 to GBP276,648 from GBP119,984 a year prior, despite COVID-19 and major disruption in Hong Kong due to anti-government protests. Reports reduced loss attributable to shareholders of GBP383,625 from GBP496,957. Says it is encouraged by the signs of economic recovery in Asia ahead of much of the world and an increased demand for digital solutions.

----------

Attis Oil & Gas Ltd - oil and gas exploration and production company - Pretax loss widened in the first half ended June 30 to USD862,000 from USD794,000 a year prior. Made progress with its asset sale programme. Following the disposal of its Austin field assets, Attis became an AIM cash shell and will be required to make an acquisition before February 5, 2021.

----------

Proactis Holdings PLC - cash management software - Revenue in the financial year ended July 31 down 8.3% to GBP49.6 million from GBP54.1 million a year prior. Pretax loss narrows to GBP19.3 million from GBP25.8 million a year before. Does not declare a final dividend, unchanged from year prior. Says commercial progress was slowed by the global pandemic and demand is still marginally subdued. Expects nonetheless to meet earnings forecast for the 2021 financial year.

----------

Angle PLC - Guildford-based liquid biopsy company - Revenue for the half year ended June 30 falls 39% to GBP235,000 from GBP384,000 a year prior. Says revenue is depressed as many research customers were shut down in the period as a result of Covid-19 restrictions. Pretax loss narrows to GBP5.8 million from GBP6.1 million a year before. "ANGLE is pursuing the opportunity for multiple revenue streams with the establishment of clinically accredited laboratories for running patient samples, development of a pharma services business with a particular focus on immunotherapy, and the design of clinical utility studies to drive adoption of the Parsortix system in clinical practice," it says.

----------

Zoltav Resources Inc - Russia-focused oil and gas exploration and production - Contract revenue is down 12% in the first half ended June 30 to RUB552.3 million, or USD 7.0 million, from RUB624.4 million a year prior. Cost of sales is narrowed to RUB380.6 million from RUB533.9 million year-on-year. Swings to a pretax profit of RUB18.7 million from RUB172.6 million a year before. Says it plans on maximising the potential of its fields.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 08:48

LONDON MARKET OPEN: Confident start before US jobs data

(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling some hawkish Federal Reserve interest rate expectations.

Read more
3 May 2024 07:58

Angle strikes supplier deal with AstraZeneca

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.